Grant Funding
Past and Present
Grant Funding
PULMONARY CENTER – ACTIVE GRANTS |
||||||
| NAME | GRANT | D.C/YR. | I.C./YR | TOTAL D.C. | TOTAL I.C. | GRANT TOTAL |
| J. Berk, M.D. |
R01 NS051306 Dates: 9/15/05-8/31/10 Effect of Diflunisal (IND68092) on Familial Amyloidosis | |||||
| J. Bernardo, M.D. | CDC RTMCC Dates: 09/01/05 – 12/31/09 Subcontract with NJ Medical School Regional Training and Medical Consultation Center |
|||||
| W. Cardoso, Ph.D. | NIH R01 HL67129 Dates: 05/01/06 – 03/31/10 Retinoic Acid Signaling in Lung Morphogenesis |
|||||
| NIH P01 HL47049 Dates: 02/01/08 – 01/30/13 Determinants of Cell Fate and Differentiaion in the Developing Lung | ||||||
| D. Center, M.D. | NIH R01 AI35680 Dates: 04/15/05 – 12/31/09 Role of Interleukin 16 in Asthma | |||||
| NIH T32 HL07035 Dates: 7/1/06 – 6/30/11 Biology of the Lung: A Multidisciplinary Program |
||||||
| W. Cruikshank, Ph.D. | NIH R43HL093903 Dates: 09/15/08 – 08/31/09 Subcontract with MDP, Sompuram, PI Identification of Therapeutic Peptides for Asthma |
|||||
| NIH R01 CA122737 Dates: 06/01/09 – 05/31/11 (expected funding through 5/31/13) Dual Role of IL-16 in Dysregulated Growth of CTCL Cells | ||||||
| S. Doctrow, Ph.D. | NIH U19AI067734 Dates: 10/01/08 – 07/31/10 Subcontract with MCW, Moulder, PI Post-irradiation intervention to mitigate and treat non-hematological injuries |
|||||
| NIH RC1 AI081294 Dates: 11/01/08 - 02/28/10 Subcontract with MCW, Medhora, P.I. Development of ACE Inhibitor as Countermeasure for Radiation-induced Lung Injury |
||||||
| A. Fine, M.D. | NIH R01 HL089795 Dates: 8/20/08 – 4/30/12 Hematopoietic Cell Fates in the Developing Lung |
|||||
| R. Goldstein | Sepracor Dates: 01/01/08-09/30/09 Pre-clinical assessment of the effect of B2-agonist isomers of formoterol on the development of emphysema |
|||||
| H. Hollingsworth, M.D. | InterMune Pharmaceuticals, Inc. Dates: 01/01/04 – 01/01/09 IPF Study 006 |
|||||
| InterMune Pharmaceuticals, Inc. Dates: 01/01/04 - 12/31/09 IPF Study 007 |
||||||
| M. Jones | Parker B. Francis Foundation Dates: 07/01/08 – 06/30/10 Post-Transcriptional Control of Cytokine Expression During Pneumonia |
|||||
| M. Joyce-Brady | BU OIT Ignition Award Dates: 11/1/07 – Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Novel Asthma Therapy |
|||||
| H. Kathuria | Cancer Center – ACS Dates: 1/01/09 – 12/31/09 Identification and function of Ets target genes in lung cancer progression | |||||
| E. Klings, M.D. |
NIH K23 Dates: 01/01/05 – 12/31/09 Gene Polymorphisms in Chronic Sickle Cell Lung Disease |
|||||
| D. Kotton, M.D. |
R21 HL086610 Dates: 04/1/08 - 03/31/10 Hemangioblast Transplantation for Reconstitution of Lung Endothelium |
|||||
| Dept. of the Army-USAMRAA Dates: 7/1/08-6/30/11 Subcontract with BMC, Fine, P.I. Acute Lung Injury: Making the Injured Lung Perform Better and Rebuilding Healthy Lungs |
||||||
| NIH R01 HL095993 Dates: 8/1/09 – 7/31/13 Derivation of Transplantable Lung Epithelial Progenitors from iPS Cells |
||||||
| J. Lu, Ph.D. | NIH R01 HL081800 Dates: 05/01/06 – 02/28/11 MicroRNA-mediated Gene Regulation in Lung Development |
|||||
| NIH R01 HL081800 ARRA Supplement Dates: 07/01/09 – 06/30/11 MicroRNA-mediated Gene Regulation in Lung Development |
||||||
| NIH R03 HL095415 Dates: 09/19/08 – 07/31/10 (W. Cardoso, dual PI) Characterization of miRNA Expression in Idiopathic Pulmonary Fibrosis (IPF) | ||||||
| Evans/DOM Faculty Merit Award Dates: 9/1/08 – 8/31/10 | ||||||
| J. Mizgerd | R01 HL079392 Dates: 7/01/08 – 05/31/10 Regulation and function of STAT3 during pneumonia |
|||||
| R01 HL068153 Dates: 7/01/08 – 05/31/12 NF-kappaB and Innate Immunity in the Lungs |
||||||
| G. O’Connor, M.D. | NIH U01 HL53941 Dates: 09/01/04 – 08/31/09 Cardiovascular Risk in Sleep Apnea The Framingham Study | |||||
| NIH AI25496 Dates: 09/30/02 – 09/30/09 Subcontract with University of Wisconsin The Inner City Asthma Consortium (ICAC) - Core |
||||||
| University of Wisconsin—NIH NIAID J033316 Dates: 3/1/04 to 10/31/09 Urban Environment and Childhood Asthma Study (URECA) |
||||||
| University of Wisconsin—NIH NIAID J033316 Subcontract Date: 7/1/06 to 7/1/09 ICATA – CTA Inner City Anti-IgE Therapy for Asthma |
||||||
| University of Wisconsin—-NIH NIAID J033316 Subcontract Dates: 9/30/07 to 9/29/09 BioCSI | ||||||
| M. O’Donnell | The Potts Memorial Foundation Dates: 12/1/08 – 11/30/09 Improving Care & Treatment Outcomes for Extensively Drug Resistant Tuberculosis Patients in South Africa |
|||||
| American Thoracic Society Dates: 7/1/09-6/30/10 Treatment Outcomes for Extensively Drug Resistant Tuberculosis and HIV |
||||||
| L. Quinton | NIH K99 HL092956 Dates: 07/08/08 – 06/30/10 Lung-Liver Axis During Pneumonia | |||||
| M. Ramirez | NIH R01 HL083034 Dates: 7/1/06-6/30/11 Lung Alveolar Type I Cell Morphogenesis |
|||||
| NIH R01 HL083034 ARRA Supplement Dates: 07/01/09 – 06/30/11 Lung Alveolar Type I Cell Morphogenesis |
||||||
| J. Saukkonen | Dept. of State Dates: 05/23/08 – 04/30/09 (will continue) Subcontract with CIMIT/MGH, Clark, P.I. CIMIT Facilitation of DOS Bio-Security Initiatives |
|||||
| CIMIT Leadership Team Dates: 10/01/08 – 09/30/11 Subcontract with CIMIT/MGH, Parrish, P.I. CIMIT Inhalation Technology Program |
||||||
| F. Schembri | Allegro Diagnostics, Inc. Dates: 08/15/08 – 08/14/09 Microarray Cell Line Standardization | |||||
| A. Spira, M.D. |
NIH R01 CA124640 Dates: 05/1/07 – 02/29/12 Airway Gene Expression in Smokers: An Early Diagnostic Biomarker for Lung Cancer |
|||||
| NIH/NIEHS U01 ES16035 Dates: 8/15/07-5/31/11 A Non-Invasive Gene-Expression Biomarker of Airway Response to Tobacco Exposure |
||||||
| NIH/NCI N01-CN 35000 Dates: 12/01/08 – 09/29/09 Laboratory Services Subcontract with Mayo, Limburg, P.I. Gene Expression-all Exon Arrays Laboratory Services |
||||||
| NIH R01 HL095388 Dates: 09/24/08 – 07/31/12 Linking Airway Genomics to the Pathogenesis and Clinical Heterogeneity of COPD |
||||||
| R. Summer, M.D. | NIH K08 HL077138 Dates: 04/01/06 – 03/31/11 Characterization of Embryonic Lung Side Population Cells |
|||||
| BU OIT Ignition Award Dates: 01/01/09 – Adiponectin in diagnosis of Acute Lung Injury | ||||||
| Gilead Sciences Dates: 2/16/09 – 2/15/11 Adiponectin and Pulmonary Hypertension | ||||||
| A. Theodore | NIH R01 HL089901 Subcontract with UCLA Dates: 09/18/08 – 7/31/13 Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease |
|||||
| R. Walter, M.D. | Flight Attendant Med. Re. Instit. Dates: 07/01/03 – 06/30/10 Biomarkers of Chronic Obstructive Pulmonary Disease |
|||||
| A. Wilson, M.D. | Flight Attendant Med. Re. Instit. Dates: 07/01/07 – 06/30/012 Cell Based Therapy for Cigarette Smoke-related Lung Disease |
|||||
| Y. Zhang, Ph.D. | NIH R01 CA100925 Dates: 01/01/05 – 12/31/09 Role of P80 pro-IL-16 in T Cell Malignancy | |||||
| GRANTS FUNDED THROUGH BMC | ||||||
| J. Brody, M.D./F. Little, M.D. | NIH U01 DE017788 Dates: 9/1/06 – 2/28/11 Subcontract with Tufts University, Walt, P.I. Microsensor Arrays for Saliva Diagnostics |
|||||
| J. Bernardo, M.D. | CDC 200-19999900099 Dates: 9/30/99-8/29/09 TB Trials Consortium | |||||
| A. Fine, M.D. | Dept. of the Army-USAMRAA Dates: 7/1/08-6/30/11 Acute Lung Injury: Making the Injured Lung Perform Better and Rebuilding Healthy Lungs |
|||||
| 10,886,042 | 4,777,058 | 45,455,943 | 19,460,462 | 64,916,405 | ||
